In this episode, I’ll discuss an article comparing half-dose to full-dose alteplase for pulmonary embolism. Subscribe on iTunes, Android, or Stitcher The risk of hemorrhage is the major drawback to therapy with alteplase for any indication. When used for pulmonary embolism, a long-standing research question has been whether 50 mg of alteplase can treat PE […]
Episode 1092: Should hot or cold compresses be used to treat extravasation?
In this episode, I’ll discuss when to use a cold or warm compress to treat extravasation. Subscribe on iTunes, Android, or Stitcher Extravasation is a complication of IV therapy that refers to the infiltration of tissues with a medication that is an irritant or vesicant. The only difference between infiltration and extravasation is that the […]
Episode 1091: What is iatrogenic hyperchloremia and what is so bad about it?
In this episode, I’ll discuss iatrogenic hyperchloremia. Subscribe on iTunes, Android, or Stitcher Iatrogenic hyperchloremia occurs when excessive chloride levels occur during the treatment of another condition. While loss of hypotonic fluids via excessive carbonic anhydrase inhibitor use is probably the first thing a pharmacist thinks of for iatrogenic causes of hyperchloremia, this is a […]
Episode 1090: Potential reasons for an unexpected positive urine barbituate screen
In this episode, I’ll discuss potential reasons for an unexpected positive urine barbiturate screen. Subscribe on iTunes, Android, or Stitcher When a urine drug screen comes up positive for barbiturates unexpectedly, healthcare practitioners often suspect the result is a false positive. Both ibuprofen and naproxen have been reported to cause a false positive urine barbiturate […]
Episode 1089: More support for the IDSA’s position on the CAP guidelines
In this episode, I’ll discuss a study that addresses the controversy over giving patients with viral infections antibiotics in the Community Acquired Pneumonia guidelines. Subscribe on iTunes, Android, or Stitcher As discussed in episode 1088, new guidelines for treating patients with community-acquired pneumonia were published earlier in 2025 by the American Thoracic Society, but unlike […]
Episode 1088: All My Antibiotics: The CAP Guideline Drama
In this episode, I’ll discuss the recent conflict between ATS and IDSA over the Community Acquired Pneumonia guidelines. Subscribe on iTunes, Android, or Stitcher New guidelines for treating patients with community-acquired pneumonia were published earlier in 2025 by the American Thoracic Society, but unlike previous versions, these were not endorsed by the Infectious Disease Society […]
Episode 1087: Make sure newbie hospital pharmacists (and students) know this about vancomycin by multiple routes of administration
In this episode, I’ll discuss whether it is ever appropriate for a patient to be on vancomycin by more than one route of administration. Subscribe on iTunes, Android, or Stitcher While IV vancomycin is indicated for a variety of infectious diseases, oral vancomycin is primarily used to treat Clostridioides difficile infection (CDI). Unlike IV metronidazole, […]
Episode 1086: Having trouble getting IV levetiracetam approved? Try this study…
In this episode, I’ll discuss the efficacy of IV push levetiracetam over slow IV infusions. Subscribe on iTunes, Android, or Stitcher IV levetiracetam is FDA labeled to be infused slowly, over 15 min. Rapid IV push administration has gained popularity with several studies supporting its safety, and some of these have been discussed recently in episode1056. […]
Episode 1085: Do Neurologically Intact Patients With Traumatic ICH on Anticoagulants Need to be Reversed?
In this episode, I’ll discuss whether the reversal of anticoagulants is necessary for neurologically intact patients with traumatic intracranial hemorrhage. Subscribe on iTunes, Android, or Stitcher While intracranial hemorrhage (ICH) has the potential to lead to a catastrophic outcome in patients with traumatic injury who are also taking oral anticoagulants, the reversal of anticoagulation is […]
Episode 1084: What patient phenotypes are most affected by delays in antibiotic therapy?
In this episode, I’ll discuss what phenotype of patients are most affected by delays in antibiotic therapy. Subscribe on iTunes, Android, or Stitcher For patients with sepsis, the link between a delay in antibiotic therapy and increased risk of mortality is well-established. However, it is possible that not all patients are affected the same way […]
Episode 1083: Takeaways for the pharmacist on best practices in airway management in critically ill adults
In this episode, I’ll discuss best practices in airway management in critically ill adults. Subscribe on iTunes, Android, or Stitcher Pharmacists who work in critical care areas have tremendous opportunities to help the care team and patient whenever tracheal intubation takes place, from preventing awareness with paralysis to managing post-intubation cardiovascular complications as has been […]
Episode 1082: Can the insulin dose for hyperkalemia be 5 units in overweight patients too?
In this episode, I’ll discuss the dose of insulin to treat hyperkalemia. Subscribe on iTunes, Android, or Stitcher Back in episodes 653 and 612 I discussed using a lower dose of insulin (5 units instead of 10) to treat hyperkalemia, and this practice has become more common because it seems to offer equivalent reduction in […]
- 1
- 2
- 3
- …
- 93
- Next Page »
